Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma

Chao Bin Yeh, Hsiu Ting Tsai, Yi Chen Chen, Wu Hsien Kuo, Tzy Yen Chen, Yi Hsien Hsieh, Ming Chih Chou, Shun Fa Yang

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background and Objectives: The purpose of this study was to investigate genetic impact of monocyte chemoattractant protein-1 (MCP-1) and its receptor chemokine receptor-2 (CCR2) gene polymorphisms on the susceptibility and clinicopathological characteristics of hepatocellular carcinoma (HCC). Methods: A total of 446 subjects, including 344 healthy controls and 102 patients with HCC, were recruited in this study and subjected to PCR-RFLP to estimate the impact of these two polymorphic variants on HCC. Results: No relationship between MCP-1 -2518G/A gene polymorphism and HCC risk was found among our recruited HCC patients and healthy controls. However, there was a significantly increased risk (AOR = 1.91; 95% CI = 1.11-3.29) of having HCC among subjects with GA heterozygotes of CCR2 V64I after adjusting for other confoundings. There was no synergistic effect between gene polymorphism and environmental risk factors, including tobacco and alcohol consumptions, as well as clinicopathological parameters of HCC for MCP-1 -2518G/A and CCR2 V64I genes, respectively. Conclusions: CCR2-64I gene polymorphism is an important factor for the susceptibility of HCC but it might not influence the clinical pathological progression of HCC, and the contribution of CCR2-64I gene polymorphism on the susceptibility of HCC could be not through the affection of liver injury-related clinical pathological characteristics.

Original languageEnglish
Pages (from-to)264-270
Number of pages7
JournalJournal of Surgical Oncology
Volume102
Issue number3
DOIs
Publication statusPublished - Sep 1 2010
Externally publishedYes

Fingerprint

Chemokine Receptors
Genetic Polymorphisms
Hepatocellular Carcinoma
Genes
Chemokine CCL2
CCR2 Receptors
Tobacco Use
Heterozygote
Alcohol Drinking
Restriction Fragment Length Polymorphisms
Polymerase Chain Reaction

Keywords

  • Chemokine receptor-2
  • Hepatocellular carcinoma
  • Monocyte chemoattractant protein-1
  • Polymorphism

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Yeh, C. B., Tsai, H. T., Chen, Y. C., Kuo, W. H., Chen, T. Y., Hsieh, Y. H., ... Yang, S. F. (2010). Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma. Journal of Surgical Oncology, 102(3), 264-270. https://doi.org/10.1002/jso.21623

Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma. / Yeh, Chao Bin; Tsai, Hsiu Ting; Chen, Yi Chen; Kuo, Wu Hsien; Chen, Tzy Yen; Hsieh, Yi Hsien; Chou, Ming Chih; Yang, Shun Fa.

In: Journal of Surgical Oncology, Vol. 102, No. 3, 01.09.2010, p. 264-270.

Research output: Contribution to journalArticle

Yeh, CB, Tsai, HT, Chen, YC, Kuo, WH, Chen, TY, Hsieh, YH, Chou, MC & Yang, SF 2010, 'Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma', Journal of Surgical Oncology, vol. 102, no. 3, pp. 264-270. https://doi.org/10.1002/jso.21623
Yeh, Chao Bin ; Tsai, Hsiu Ting ; Chen, Yi Chen ; Kuo, Wu Hsien ; Chen, Tzy Yen ; Hsieh, Yi Hsien ; Chou, Ming Chih ; Yang, Shun Fa. / Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma. In: Journal of Surgical Oncology. 2010 ; Vol. 102, No. 3. pp. 264-270.
@article{462e433351b4419294effe898b9b6bf9,
title = "Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma",
abstract = "Background and Objectives: The purpose of this study was to investigate genetic impact of monocyte chemoattractant protein-1 (MCP-1) and its receptor chemokine receptor-2 (CCR2) gene polymorphisms on the susceptibility and clinicopathological characteristics of hepatocellular carcinoma (HCC). Methods: A total of 446 subjects, including 344 healthy controls and 102 patients with HCC, were recruited in this study and subjected to PCR-RFLP to estimate the impact of these two polymorphic variants on HCC. Results: No relationship between MCP-1 -2518G/A gene polymorphism and HCC risk was found among our recruited HCC patients and healthy controls. However, there was a significantly increased risk (AOR = 1.91; 95{\%} CI = 1.11-3.29) of having HCC among subjects with GA heterozygotes of CCR2 V64I after adjusting for other confoundings. There was no synergistic effect between gene polymorphism and environmental risk factors, including tobacco and alcohol consumptions, as well as clinicopathological parameters of HCC for MCP-1 -2518G/A and CCR2 V64I genes, respectively. Conclusions: CCR2-64I gene polymorphism is an important factor for the susceptibility of HCC but it might not influence the clinical pathological progression of HCC, and the contribution of CCR2-64I gene polymorphism on the susceptibility of HCC could be not through the affection of liver injury-related clinical pathological characteristics.",
keywords = "Chemokine receptor-2, Hepatocellular carcinoma, Monocyte chemoattractant protein-1, Polymorphism",
author = "Yeh, {Chao Bin} and Tsai, {Hsiu Ting} and Chen, {Yi Chen} and Kuo, {Wu Hsien} and Chen, {Tzy Yen} and Hsieh, {Yi Hsien} and Chou, {Ming Chih} and Yang, {Shun Fa}",
year = "2010",
month = "9",
day = "1",
doi = "10.1002/jso.21623",
language = "English",
volume = "102",
pages = "264--270",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma

AU - Yeh, Chao Bin

AU - Tsai, Hsiu Ting

AU - Chen, Yi Chen

AU - Kuo, Wu Hsien

AU - Chen, Tzy Yen

AU - Hsieh, Yi Hsien

AU - Chou, Ming Chih

AU - Yang, Shun Fa

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Background and Objectives: The purpose of this study was to investigate genetic impact of monocyte chemoattractant protein-1 (MCP-1) and its receptor chemokine receptor-2 (CCR2) gene polymorphisms on the susceptibility and clinicopathological characteristics of hepatocellular carcinoma (HCC). Methods: A total of 446 subjects, including 344 healthy controls and 102 patients with HCC, were recruited in this study and subjected to PCR-RFLP to estimate the impact of these two polymorphic variants on HCC. Results: No relationship between MCP-1 -2518G/A gene polymorphism and HCC risk was found among our recruited HCC patients and healthy controls. However, there was a significantly increased risk (AOR = 1.91; 95% CI = 1.11-3.29) of having HCC among subjects with GA heterozygotes of CCR2 V64I after adjusting for other confoundings. There was no synergistic effect between gene polymorphism and environmental risk factors, including tobacco and alcohol consumptions, as well as clinicopathological parameters of HCC for MCP-1 -2518G/A and CCR2 V64I genes, respectively. Conclusions: CCR2-64I gene polymorphism is an important factor for the susceptibility of HCC but it might not influence the clinical pathological progression of HCC, and the contribution of CCR2-64I gene polymorphism on the susceptibility of HCC could be not through the affection of liver injury-related clinical pathological characteristics.

AB - Background and Objectives: The purpose of this study was to investigate genetic impact of monocyte chemoattractant protein-1 (MCP-1) and its receptor chemokine receptor-2 (CCR2) gene polymorphisms on the susceptibility and clinicopathological characteristics of hepatocellular carcinoma (HCC). Methods: A total of 446 subjects, including 344 healthy controls and 102 patients with HCC, were recruited in this study and subjected to PCR-RFLP to estimate the impact of these two polymorphic variants on HCC. Results: No relationship between MCP-1 -2518G/A gene polymorphism and HCC risk was found among our recruited HCC patients and healthy controls. However, there was a significantly increased risk (AOR = 1.91; 95% CI = 1.11-3.29) of having HCC among subjects with GA heterozygotes of CCR2 V64I after adjusting for other confoundings. There was no synergistic effect between gene polymorphism and environmental risk factors, including tobacco and alcohol consumptions, as well as clinicopathological parameters of HCC for MCP-1 -2518G/A and CCR2 V64I genes, respectively. Conclusions: CCR2-64I gene polymorphism is an important factor for the susceptibility of HCC but it might not influence the clinical pathological progression of HCC, and the contribution of CCR2-64I gene polymorphism on the susceptibility of HCC could be not through the affection of liver injury-related clinical pathological characteristics.

KW - Chemokine receptor-2

KW - Hepatocellular carcinoma

KW - Monocyte chemoattractant protein-1

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=77956377669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956377669&partnerID=8YFLogxK

U2 - 10.1002/jso.21623

DO - 10.1002/jso.21623

M3 - Article

C2 - 20740585

AN - SCOPUS:77956377669

VL - 102

SP - 264

EP - 270

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -